Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis

Author:

Van Citters Aricca D.ORCID,Aliaj Enid,Alvarez Jessica A.,Brown Cynthia D.ORCID,Cary Jamie,Cravens Rachel,Frederick Carla A.,Georgiopoulos Anna M.ORCID,Goss Christopher H.,Kazmerski Traci M.ORCID,King Joel R.,Lawrence Melanie,Lovell Caitlyn,Roman Christina,Tillman Laura,Yu Elizabeth

Funder

Cystic Fibrosis Foundation

Publisher

Elsevier BV

Reference29 articles.

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: 2022 Annual Data Report Bethesda, MD: Cystic Fibrosis Foundation; 2023.

2. The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation;Caverly;Clin Chest Med,2022

3. Update on Clinical Outcomes of Highly Effective Modulator Therapy;Gifford;Clin Chest Med,2022

4. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials;Mayer-Hamblett;Lancet Respir Med,2023

5. The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: the SIMPLIFY-MCC Study;Donaldson;J Cyst Fibros,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3